Title |
The structural network of Interleukin-10 and its implications in inflammation and cancer
|
---|---|
Published in |
BMC Genomics, May 2014
|
DOI | 10.1186/1471-2164-15-s4-s2 |
Pubmed ID | |
Authors |
Ece Saliha Acuner-Ozbabacan, Billur Hatice Engin, Emine Guven-Maiorov, Guray Kuzu, Serena Muratcioglu, Alper Baspinar, Zhong Chen, Carter Van Waes, Attila Gursoy, Ozlem Keskin, Ruth Nussinov |
Abstract |
Inflammation has significant roles in all phases of tumor development, including initiation, progression and metastasis. Interleukin-10 (IL-10) is a well-known immuno-modulatory cytokine with an anti-inflammatory activity. Lack of IL-10 allows induction of pro-inflammatory cytokines and hinders anti-tumor immunity, thereby favoring tumor growth. The IL-10 network is among the most important paths linking cancer and inflammation. The simple node-and-edge network representation is useful, but limited, hampering the understanding of the mechanistic details of signaling pathways. Structural networks complete the missing parts, and provide details. The IL-10 structural network may shed light on the mechanisms through which disease-related mutations work and the pathogenesis of malignancies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
Spain | 1 | 1% |
Unknown | 67 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 22% |
Researcher | 13 | 19% |
Student > Bachelor | 6 | 9% |
Student > Postgraduate | 5 | 7% |
Professor | 4 | 6% |
Other | 14 | 20% |
Unknown | 12 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 23% |
Medicine and Dentistry | 14 | 20% |
Agricultural and Biological Sciences | 11 | 16% |
Computer Science | 5 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 6 | 9% |
Unknown | 15 | 22% |